Ting-Yuan (David) Cheng, PhD
Dr. David Cheng is a cancer epidemiologist. He received his Master in Johns Hopkins Bloomberg School of Public Health and Ph.D. in Epidemiology from the University of Washington and training in Fred Hutchinson Cancer Research Center. His laboratory has been devoted to understanding cancer etiology and factors that affect cancer outcomes in different racial and ethnic populations. His approaches involve molecular epidemiology and molecular pathological epidemiology. A current emphasis is to evaluate racial differences in the etiology of breast cancer subtypes. He is currently funded by an NIH/NCI K07 Career Development Award (2016-2021), with the goal of examining the association of the mammalian target of rapamycin (mTOR), an obesity-related biological pathway, with estrogen receptor negative (ER-) and basal-like breast cancer in African American women. At UF, he is also devoted to developing a cancer survivor cohort in HealthStreet, a community-outreach research engagement program that has enrolled >10,000 participants in Florida. The goal is to expand the existing infrastructure of HealthStreet to develop a resource to support research in the areas of cancer survivorship, comorbidity, and disparities in community settings. He maintains close collaboration with a number of institutes and cohort studies, including Roswell Park Comprehensive Cancer Center (where he is adjunct faculty), Kaiser Permanente Division of Research, and Women’s Health Initiatives. Dr. Cheng’s research has been published in a number of high-profile journals, including JNCI: Journal of the National Cancer Institute, American Journal of Epidemiology, and Carcinogenesis. He is also an associate editor of the JNCI Cancer Spectrum.